You Are Here    News

People with HIV are at risk for liver fibrosis and steatosis
by Liz Highleyman, 2017-08-21 12:10
Metabolic syndrome, type 2 diabetes and obesity are risk factors for the development of liver fibrosis and steatosis (liver fat accumulation) in people living with HIV, including those who do not have viral hepatitis co-infection, according to research presented at the 9th International AIDS Society Conference on HIV Science (IAS

Switching from efavirenz to raltegravir leads to significant improvements in fatty liver disease in people with HIV
by Michael Carter, 2017-08-17 08:00
Switching to raltegravir from efavirenz is associated with significant improvements in liver steatosis for HIV-positive people with non-alcoholic fatty liver disease, Spanish investigators report in the online edition of Clinical Infectious Diseases. The benefits of changing therapy were observed in people with and without active hepatitis C virus (HCV) co-infection.

Peripheral artery disease more common in people with HIV with lower CD4 counts
by Keith Alcorn, 2017-08-15 14:40
Peripheral artery disease, one of the most common forms of cardiovascular disease, occurs more frequently in people with HIV who have CD4 cell counts below 500, regardless of whether they smoke or have other risk factors for cardiovascular disease, an analysis of the large US Veterans Aging Cohort Study has